Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients

Journal of Diabetes and its Complications

Volumn 11, Issue 2, 1997, Pages 131-136

  Zuanetti, Giulio ^a   Latini, Roberta ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; LISINOPRIL;

DIABETES MELLITUS; DRUG EFFICACY; FEMALE; FIBRINOLYSIS; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL DISCHARGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE;

EID: 0030950459     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00100-1     Document Type: Article

References (32)

1. Smith JW, Marcus FI, Serokman R, Multicenter Postinfarction Research Group: Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 54:718-721, 1984.
2. Singer DE, Moulton AW, Nathan DM: Diabetic myocardial infarction: interaction of diabetes with other preinfarction risk factors. Diabetes 38:350-357, 1989.
3. Stone PH, Muller JE, Hartwell T, et al.: The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 14:49-57, 1989.
4. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM: Acute myocardial infarction in diabetes mellitus and significance of congestive heart as a prognostic factor. Am J Cardiol 62:665-669, 1988.
5. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG, GISSI-2 Investigators: Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J Am Coll Cardiol 22:1788-1794, 1993.
6. Lee KL, Woodlief LH, Topol EJ, Weaver D, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM, for the GUSTO-I Investigators: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarc- tion. Results from an international trial of 41021 patients. Circulation 91:1659-1668, 1995.
7. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud GL, for the TIMI Investigators: Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II. Circulation 85:1254-1264, 1992.
8. Zuanetti G, Latin! R, Maggioni AP, Santoro L, Franzosi MG, Tognoni G, GISSI-3 investigators: Prognosis of diabetic patients after myocardial infarction: effect of early treatment with ACE-inhibitors. J Am Coll Cardiol 27 (suppl A):319A, 1996.
9. G1SSI-2 Investigators: Determinants of 6-month mortality in survivors of myocardial infarction after thrombolvsis: Results from the GISSI-2 data-base. Circulation 88:416-429, 1993.
10. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S: In-hospital and 1-year mortality in 1, 524 women after myocardial infarction: Comparison with 4, 315 men. Circulation 83:484-491, 1991.
11. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L, on behalf of the DIGAMI Study Group: randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): Effects on mortality at 1 year. J Am Coll Cardiol 26:57-65, 1995.
12. Aoki I, Shimoyama K, Aoki N, Homori M, Yanagisawa A, Nakahara K, Kawai Y, Kitamura S, Ishikawa K: Platelet-dependent thrombin generation in patients with diabetes mellitus: Effects of glycemie control on coagulability in diabetes. J Am Coll Cardiol 27:560-566, 1996.
13. Woodfield SL, Lundergan CF, Reiner JS, Deychak Y, Thompson M, Califf R, Ross A, GUSTO Angiographie Investigators: Angiographie findings in diabetics treated with thrombolytic therapy after acute myocardial infarction. JAm Coll Cardiol 25 (suppl A):105A, 1995.
14. Fibrinolytic Therapy Trialists' (FIT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343:311-322, 1994.
15. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol EJ, and the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol 21:920-925, 1993.
16. ISIS-2 Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS 2 Lancet ii:349-360, 1988.
17. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. B M J 308:81-106, 1994.
18. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J: Blockers and sudden cardiac death. Ann Intern Med 123:358-367, 1995.
19. Malmberg K, Ryden L: Intense metabolic control decreases long-term mortality in diabetics with acute myocardial infarction: predictors of one year mortality. J Am Coll Cardiol 27(suppl A):82A, 1996.
20. Muller J, Morrison J, Stone P, et al.: Nifedipine therapy for patients with threatened and acute myocardial infarction: A randomized double-blind, placebo-controlled comparison. Circulation 69:740-747, 1984.
21. Wilcox RG, Hampton JR, Banks DC, Birkhead JS, Brooksby IAB, Burns-Cox CJ, Hayes M], Joy MD, Malcolm AD, Mather HG, Rowley JM: Trial of early nifedipine in acute myocardial infarction: The TRENT study. B M J 293:1204-1208, 1986.
22. Goldbourt U, Behar S, Reicher-Reiss H, et al: Early administration of nifedipine in suspected acute myocardial infarction: The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med 153:345 353, 1993.
23. Gibson R, Boden WE, Theroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MH, Schlant RC, Kleiger RE, Young PA, Schechtman K, Perryman B, Roberts R, and the Diltiazem Reinfarction Study Group: Diltiazem and reinfarction in patients with non-Q wave myocardial infarction. N Engl J Med 315:423-429, 1986.
24. The Multicenter Diltiazem Post Infarction Trial Research Group: The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319:385-392, 1988.
25. The Danish Study Group on Verapamil in Myocardial Infarction: Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II [DAVIT II]). Am J Cardiol 66:779-785, 1990.
26. Yusuf S, Held P, Furberg C: Update on the effects of Calcium antagonists in myocardial infarction or angina in light of the Danish Verapamil Infarction Trial II (DAVIT II) and other recent studies. Am J Cardiol 67:1295-1297, 1991.
27. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510-2516, 1993.
28. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA: Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 27:567-574, 1996.
29. Boden WE, Messerli FH, Hansen JF, Schechtman KB: Heart rate-lowering calcium channel blockers (diltiazem, verapamil) do not adversely affect long-term cardiac death or non-fatal infarction in post-infarction patients: Data pooled from 3 randomized, placebo-controlled clinical trials of 5, 677 patients. J Am Coll Cardiol 27(suppl A):319A, 1996.
30. Moye LA, Pfeffer MA, Wun CC, Davis BR, Geltman E, Hayes D, Farnham DJ, Randall OS , Dinh H, Arnold JMO, Kupersmith J, Hager D, Classer SP, Biddle T, Ha wkins CM, Braunwald E, for the SAVE Investigators: Uniformity of captopril benefit in the SAVE study: subgroup analysis. Eur HeartJ 15:2-8, 1994.
31. Gruppo Italiano per lo Studio della Sopravvivenza nel1'Infarto Miocardico: GISSI-3: Effects of lisinopril and transdermal glyceryl trinirrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343:1115-1121, 1994
32. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H, CONSENSUS II Study Group: Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. New Engl J Med 327:678-684, 1992.